David a. Ricks, Lilly’s Chair and CEO
INDIANAPOLIS, Oct. 4, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced changes to its executive leadership team. Over the last two decades, Mason has served in the leadership of Lilly’s Neuroscience and Diabetes businesses to achieve significant growth and leading market positions. Mike Mason, executive vice president and president of Lilly Diabetes and Obesity, will retire from […]